Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
Live Science on MSN
Experimental drug doubles one-year survival in pancreatic cancer
A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those ...
New experimental medications seem to extend survival with the hard-to-treat cancer.
A medical oncologist called the late-stage clinical trial results “remarkable,” though Sasse said the drug means his body ...
Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Drugmakers have poured billions of dollars into developing ADCs. The medicines are designed to deliver potent ...
Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases. In some patients, the disease returns or progresses within six months of the ...
The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction. Microscope image of colon cancer cells. The mouse model used in this study mimics ...
Add Yahoo as a preferred source to see more of our stories on Google. Northwestern scientists turned a decades-old chemotherapy drug into a precision cancer killer. (CREDIT: Shutterstock) Cancer ...
SP16 is an investigational intravenous therapy designed to treat chemotherapy-induced pain and peripheral neuropathy, also ...
Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Stream Los Angeles News for free, 24/7, wherever you are. Drugmakers have poured billions of dollars into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results